We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$7.55B
AUM Growth
+$207M
Cap. Flow
+$12.8M
Cap. Flow %
0.17%
Top 10 Hldgs %
25.66%
Holding
574
New
32
Increased
147
Reduced
149
Closed
28

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$58.2M
2
AAPL icon
Apple
AAPL
+$27.2M
3
LLY icon
Eli Lilly
LLY
+$24.1M
4
ANET icon
Arista Networks
ANET
+$9.78M
5
BLMN icon
Bloomin' Brands
BLMN
+$9.38M

Top Sells

Rank Stock Value
1
NUE icon
Nucor
NUE
+$50.9M
2
NVDA icon
NVIDIA
NVDA
+$37.6M
3
AMAT icon
Applied Materials
AMAT
+$13M
4
COST icon
Costco
COST
+$11.9M
5
GNRC icon
Generac Holdings
GNRC
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 35.83%
2 Healthcare 16.89%
3 Financials 10.88%
4 Consumer Discretionary 9.28%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRE icon
301
Sempra
SRE
$57.9B
$2M 0.03%
26,398
+2,697
+11% +$199K
ITW icon
302
Illinois Tool Works
ITW
$82.6B
$1.99M 0.03%
8,394
+1,082
+15% +$267K
PASG icon
303
Passage Bio
PASG
$14.4M
$1.96M 0.03%
122,790
MDLZ icon
304
Mondelez International
MDLZ
$79.5B
$1.93M 0.03%
29,150
-1,689
-5% -$116K
AMT icon
305
American Tower
AMT
$80.8B
$1.92M 0.03%
9,823
-4,538
-32% -$848K
CSX icon
306
CSX Corp
CSX
$93.4B
$1.89M 0.03%
57,323
+12,678
+28% +$431K
XENE icon
307
Xenon Pharmaceuticals
XENE
$6.06B
$1.87M 0.02%
50,000
EQR icon
308
Equity Residential
EQR
$24.9B
$1.86M 0.02%
27,300
EWBC icon
309
East-West Bancorp
EWBC
$17.9B
$1.85M 0.02%
25,803
+2,677
+12% +$199K
BRK.A icon
310
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.84M 0.02%
3
ONC
311
BeOne Medicines Ltd
ONC
$32.8B
$1.83M 0.02%
12,600
MFC icon
312
Manulife Financial
MFC
$73.9B
$1.83M 0.02%
68,900
SPG icon
313
Simon Property Group
SPG
$74.4B
$1.8M 0.02%
12,000
-1,700
-12% -$250K
TS icon
314
Tenaris
TS
$28.9B
$1.79M 0.02%
60,000
AFL icon
315
Aflac
AFL
$64.9B
$1.76M 0.02%
19,700
APLS
316
DELISTED
Apellis Pharmaceuticals
APLS
$1.74M 0.02%
42,000
CFG icon
317
Citizens Financial Group
CFG
$30.3B
$1.74M 0.02%
50,114
+5,686
+13% +$198K
SLB icon
318
SLB Ltd
SLB
$73.6B
$1.74M 0.02%
36,908
+4,164
+13% +$201K
EXEL icon
319
Exelixis
EXEL
$13.3B
$1.68M 0.02%
74,500
FANG icon
320
Diamondback Energy
FANG
$57.1B
$1.67M 0.02%
8,370
GPN icon
321
Global Payments
GPN
$23B
$1.66M 0.02%
17,543
+1,800
+11% +$198K
ITCI
322
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.66M 0.02%
23,400
BHVN icon
323
Biohaven
BHVN
$2.03B
$1.65M 0.02%
46,900
CERE
324
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$1.62M 0.02%
40,000
OCUL icon
325
Ocular Therapeutix
OCUL
$1.79B
$1.59M 0.02%
235,800

Similar funds

Erste Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Erste Asset Management held 574 positions worth $7.55B, up 2.8% from $7.34B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Erste Asset Management's Q2 2024 filing shows 32 new, 147 increased, 149 reduced and 28 closed positions. Its largest new stake was Zillow: 200,000 shares worth $9.36M. The largest sale was Nucor, an estimated $50.9M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.

  • Erste Asset Management's largest Q2 2024 buy was Zillow: 200,000 shares worth $9.36M.
  • Erste Asset Management added most to Progressive in Q2 2024, an estimated $58.2M increase.
  • Erste Asset Management's biggest Q2 2024 reduction was Nucor, cutting an estimated $50.9M.
  • Erste Asset Management fully exited Fomento Económico Mexicano in Q2 2024, selling an estimated $8.44M.
  • Erste Asset Management's ten largest holdings make up 26% of its $7.55B portfolio in Q2 2024.
  • Erste Asset Management opened 32 new positions and closed 28 in Q2 2024.
  • Erste Asset Management's portfolio value rose 2.8% quarter-over-quarter to $7.55B.

Based on Erste Asset Management's 13F filing for Q2 2024, filed 26 Nov 2024.